Inhibrx Biosciences, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2023 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Inhibrx Biosciences, Inc. quarterly Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2023 to Q3 2024.
  • Inhibrx Biosciences, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 15.5M shares, a 31.2% increase year-over-year.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.